tradingkey.logo
搜索

iSpecimen Inc

ISPC
添加自选
1.880USD
+0.050+2.73%
收盘 07-31 16:00美东报价延迟15分钟
34.85K总市值
亏损市盈率 TTM

关于 iSpecimen Inc 公司

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

iSpecimen Inc简介

公司代码ISPC
公司名称iSpecimen Inc
上市日期Jun 17, 2021
CEOField (Katharyn)
员工数量24
证券类型Ordinary Share
年结日Jun 17
公司地址8 Cabot Road
城市WOBURN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编08101
电话17813016700
网址https://www.ispecimen.com/
公司代码ISPC
上市日期Jun 17, 2021
CEOField (Katharyn)

iSpecimen Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--

常见问题

iSpecimen Inc的前五大股东是谁?

iSpecimen Inc 的前五大股东如下:Mr. Avtar Dhaliwal

有多少机构持有iSpecimen Inc(ISPC)的股份?

截至2026Q1,共有31家机构持有iSpecimen Inc的股份,合计持有的股份价值约为5.11K,占公司总股份的0.39%。与2025Q4相比,机构持股有所增加,增幅为-79730.00。

哪个业务部门对iSpecimen Inc的收入贡献最大?

在2026Q1,Specimens – contracts with customers业务部门对iSpecimen Inc的收入贡献最大,创收95.82K,占总收入的89.89%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有